BRIEF-Medicinova announces interim data from clinical trial of MN-166 (ibudilast) in ALS
April 20, 2016 at 06:22 AM EDT
* Announces interim data from clinical trial of MN-166 (ibudilast) in ALS presented at the American Academy of Neurology (AAN) 68th annual meeting in Vancouver, Canada
